<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Macheras, Panos</style></author><author><style face="normal" font="default" size="100%">Tsekouras, Athanasios A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Finite Absorption Time (FAT) concept en route to PBPK modeling and pharmacometrics</style></title><secondary-title><style face="normal" font="default" size="100%">JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">FEB</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">1</style></number><publisher><style face="normal" font="default" size="100%">SPRINGER/PLENUM PUBLISHERS</style></publisher><pub-location><style face="normal" font="default" size="100%">233 SPRING ST, NEW YORK, NY 10013 USA</style></pub-location><volume><style face="normal" font="default" size="100%">50</style></volume><pages><style face="normal" font="default" size="100%">5-10</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">The concept of Finite Absorption Time (FAT) for oral drug administration is set to affect pharmacokinetic analyses, Physiologically-based Pharmacokinetics simulations, and Pharmacometrics.</style></abstract><work-type><style face="normal" font="default" size="100%">Article</style></work-type></record></records></xml>